Tenofovir alafenamide (BioDeep_00000683642)
代谢物信息卡片
propan-2-yl (2S)-2-[[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-phenoxyphosphoryl]amino]propanoate
化学式: C21H29N6O5P (476.1936954)
中文名称: 替诺福韦艾拉酚胺, 磷丙替诺福韦, GS7340中间体
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CC(C)OC(=O)C(C)NP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OC3=CC=CC=C3
InChI: InChI=1S/C21H29N6O5P/c1-14(2)31-21(28)16(4)26-33(29,32-17-8-6-5-7-9-17)13-30-15(3)10-27-12-25-18-19(22)23-11-24-20(18)27/h5-9,11-12,14-16H,10,13H2,1-4H3,(H,26,29)(H2,22,23,24)
描述信息
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors
C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor
C254 - Anti-Infective Agent > C281 - Antiviral Agent
同义名列表
数据库引用编号
10 个数据库交叉引用编号
- ChEBI: CHEBI:90926
- KEGGdrug: D10428
- PubChem: 9574768
- PubChem: 72370618
- DrugBank: DB09299
- ChEMBL: CHEMBL2107825
- ChEMBL: CHEMBL4303549
- CAS: 379270-37-8
- CAS: 383365-04-6
- CAS: 379270-36-7
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Dathan M Byonanebye, Mark N Polizzotto, Fernando Maltez, Andri Rauch, Katharina Grabmeier-Pfistershammer, Ferdinand Wit, Stéphane De Wit, Antonella Castagna, Antonella d'Arminio Monforte, Cristina Mussini, Jan-Christian Wasmuth, Eric Fontas, Irene Abela, Mario Sarcletti, Loveleen Bansi-Matharu, Nadine Jaschinski, Lars Peters, Sean R Hosein, Vani Vannappagari, Cal Cohen, Emiliano Bissio, Amanda Mocroft, Matthew Law, Lene Ryom, Kathy Petoumenos. Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts.
The lancet. HIV.
2024 May; 11(5):e321-e332. doi:
10.1016/s2352-3018(23)00328-4. [PMID: 38621392] - Jen-Yu Hsu, Hsin-Yun Sun, Ling-Ya Chen, Sui-Yuan Chang, Yu-Chung Chuang, Yu-Shan Huang, Yi-Ching Su, Wen-Chun Liu, Chien-Ching Hung. Weight and metabolic changes among virally suppressed people with HIV who switched to co-formulated bictegravir/emtricitabine/tenofovir alafenamide.
Journal of global antimicrobial resistance.
2024 Mar; 36(?):426-435. doi:
10.1016/j.jgar.2023.10.012. [PMID: 37923129] - Lin Gan, Xiaoxin Xie, Yanhua Fu, Yebing Song, Chunli Song, Tingting Ren, Hai Long. Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide fumarate for adult patients with human immunodeficiency virus-1 in China: a retrospective real-world cohort study.
Expert review of anti-infective therapy.
2023 Dec; ?(?):1-7. doi:
10.1080/14787210.2023.2292544. [PMID: 38058002] - Yinghua Wei, Jin Li, Ruhong Xu, Li Wen, Yiming Deng, Lixia He, Huijun Zhong, Yanhao Wang. Efficacy and safety profiles of dolutegravir plus lamivudine vs. bictegravir/emtricitabine/tenofovir alafenamide in therapy-naïve adults with HIV-1.
Chinese medical journal.
2023 Nov; ?(?):. doi:
10.1097/cm9.0000000000002907. [PMID: 37914678] - Sandra Rotea-Salvo, Víctor Giménez-Arufe, Alejandro Martínez-Pradeda, Carla Fernández-Oliveira, Álvaro Mena-de-Cea, Luis Margusino-Framiñán, Isabel Martín-Herranz, Purificación Cid-Silva. Lipid profile changes associated with antiretroviral therapies in a real-world cohort.
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.
2023 Sep; 47(5):T210-T217. doi:
10.1016/j.farma.2023.07.005. [PMID: 37673703] - Sandra Rotea-Salvo, Víctor Giménez-Arufe, Alejandro Martínez-Pradeda, Carla Fernández-Oliveira, Álvaro Mena-de-Cea, Luis Margusino-Framiñán, Isabel Martín-Herranz, Purificación Cid-Silva. Lipid profile changes associated with antiretroviral therapies in a real-world cohort.
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.
2023 Jun; ?(?):. doi:
10.1016/j.farma.2023.04.007. [PMID: 37349200] - Alessandro Lazzaro, Diana Bianchini, Elio Gentilini Cacciola, Ivano Mezzaroma, Mario Falciano, Carolina Andreoni, Caterina Fimiani, Letizia Santinelli, Luca Maddaloni, Ginevra Bugani, Giancarlo Ceccarelli, Claudio Maria Mastroianni, Gabriella d'Ettorre. Immune Reconstitution and Safe Metabolic Profile after the Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate among Virologically Controlled PLWH: A 96 Week Update from the BICTEL Cohort.
Viruses.
2023 05; 15(6):. doi:
10.3390/v15061222. [PMID: 37376522] - Ryoko Sekiya, Takashi Muramatsu, Akito Ichiki, Yushi Chikasawa, Masato Bingo, Mihoko Yotsumoto, Takeshi Hagiwara, Kagehiro Amano, Ei Kinai. Young age is a key determinant of body weight gain after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in Japanese people living with HIV.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
2023 Feb; 29(2):171-178. doi:
10.1016/j.jiac.2022.10.014. [PMID: 37589078] - Nicola Squillace, Elena Ricci, Paolo Maggi, Lucia Taramasso, Barbara Menzaghi, Giuseppe Vittorio De Socio, Stefania Piconi, Benedetto Maurizio Celesia, Giancarlo Orofino, Eleonora Sarchi, Giovanni Francesco Pellicanò, Filomena Simeone, Laura Valsecchi, Alessandra Bandera, Giovanni Cenderello, Letizia Attala, Goffredo Angioni, Katia Falasca, Antonio Cascio, Olivia Bargiacchi, Antonio Di Biagio, Paolo Bonfanti. Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir.
PloS one.
2023; 18(8):e0289132. doi:
10.1371/journal.pone.0289132. [PMID: 37556481] - Franco Maggiolo, Giuliano Rizzardini, Jean-Michel Molina, Federico Pulido, Stephane De Wit, Linos Vandekerckhove, Juan Berenguer, Michelle L D'Antoni, Christiana Blair, Susan K Chuck, David Piontkowsky, Hal Martin, Richard Haubrich, Ian R McNicholl, Joel Gallant. Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed people ≥65 years of age.
HIV medicine.
2023 01; 24(1):27-36. doi:
10.1111/hiv.13319. [PMID: 35527425] - Liqin Sun, Yun He, Liumei Xu, Fang Zhao, Yang Zhou, Lukun Zhang, Qiaoli Peng, Haitao Zhang, Qiuyue Zhang, Tingzhi Cao, Ying Song, Siyuan Wang, Man Rao, Xinyun Jia, Xiaoning Liu, Jing Zhou, Bin Ju, Hui Wang, Jiaye Liu. Higher Risk of Dyslipidemia With Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide than Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate Among Antiretroviral-Naive People Living With HIV in China.
Journal of acquired immune deficiency syndromes (1999).
2022 10; 91(S1):S8-S15. doi:
10.1097/qai.0000000000003040. [PMID: 36094509] - William Liu, Sarah Yu, Bingfang Yan. Effect of alcohol exposure on the efficacy and safety of tenofovir alafenamide fumarate, a major medicine against human immunodeficiency virus.
Biochemical pharmacology.
2022 10; 204(?):115224. doi:
10.1016/j.bcp.2022.115224. [PMID: 36007574] - Olayemi Osiyemi, Stéphane De Wit, Faïza Ajana, Fiona Bisshop, Joaquín Portilla, Jean Pierre Routy, Christoph Wyen, Mounir Ait-Khaled, Peter Leone, Keith A Pappa, Ruolan Wang, Jonathan Wright, Nisha George, Brian Wynne, Michael Aboud, Jean van Wyk, Kimberly Y Smith. Efficacy and Safety of Switching to Dolutegravir/Lamivudine Versus Continuing a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Results Through Week 144 From the Phase 3, Noninferiority TANGO Randomized Trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
2022 09; 75(6):975-986. doi:
10.1093/cid/ciac036. [PMID: 35079789] - Tahrima Kayes, Harry Crane, Allison Symonds, Julie Dumond, Mackenzie Cottrell, Julia Di Girolamo, Sicha Manandhar, Tien Huey Lim, Edward Gane, Angela Kashuba, Miriam T Levy. Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection.
Alimentary pharmacology & therapeutics.
2022 Aug; 56(3):510-518. doi:
10.1111/apt.17040. [PMID: 35599363] - Miriam T Levy, Angela Kashuba, Edward Gane. Plasma and breast milk pharmacokinetics of tenofovir alafenamide of mothers with chronic hepatitis B infection-Authors' reply.
Alimentary pharmacology & therapeutics.
2022 Aug; 56(3):548-549. doi:
10.1111/apt.17102. [PMID: 35804469] - Mei-Hsuan Lee. Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection.
Alimentary pharmacology & therapeutics.
2022 Aug; 56(3):546-547. doi:
10.1111/apt.17079. [PMID: 35804473] - Jihye Lim, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi. Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naïve chronic hepatitis B.
Liver international : official journal of the International Association for the Study of the Liver.
2022 07; 42(7):1517-1527. doi:
10.1111/liv.15261. [PMID: 35343041] - Eiichi Ogawa, Makoto Nakamuta, Toshimasa Koyanagi, Aritsune Ooho, Norihiro Furusyo, Eiji Kajiwara, Kazufumi Dohmen, Akira Kawano, Takeaki Satoh, Kazuhiro Takahashi, Koichi Azuma, Nobuyuki Yamashita, Naoki Yamashita, Rie Sugimoto, Hiromasa Amagase, Masami Kuniyoshi, Yasunori Ichiki, Chie Morita, Masaki Kato, Shinji Shimoda, Hideyuki Nomura, Jun Hayashi. Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B: Week 144 results from a real-world, multicentre cohort study.
Alimentary pharmacology & therapeutics.
2022 Jun; ?(?):. doi:
10.1111/apt.17107. [PMID: 35735794] - Kai Juhani Kauppinen, Inka Aho, Jussi Sutinen. Switching from tenofovir alafenamide to tenofovir disoproxil fumarate improves lipid profile and protects from weight gain.
AIDS (London, England).
2022 Jun; ?(?):. doi:
10.1097/qad.0000000000003245. [PMID: 35727143] - Jennifer Lagoutte-Renosi, Mylène Flammang, Didier Ducloux, Jamal Bamoulid, Pierre-Yves Royer, Quentin Lepiller, Anne-Laure Clairet, Siamak Davani, Patrice Muret. Bictegravir/emtricitabine/tenofovir alafenamide combination in the management of kidney transplant patients with HIV receiving immunosuppressants.
Journal of chemotherapy (Florence, Italy).
2022 May; 34(3):199-202. doi:
10.1080/1120009x.2021.1940436. [PMID: 34180378] - Chan-Young Jung, Hyung Woo Kim, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim. Higher risk of kidney function decline with entecavir than tenofovir alafenamide in patients with chronic hepatitis B.
Liver international : official journal of the International Association for the Study of the Liver.
2022 05; 42(5):1017-1026. doi:
10.1111/liv.15208. [PMID: 35220649] - E Sinakos, P Panas, N Fragkou, N Antoniadis, G Katsanos, E Tsakni, T Oikonomou, A Notopoulos, G Tsoulfas, I Goulis, E Akriviadis. Tenofovir alafenamide prophylaxis post-liver transplantation: a real-world study in patients with chronic kidney disease.
Acta gastro-enterologica Belgica.
2022 Apr; 85(2):331-337. doi:
10.51821/85.2.9577. [PMID: 35709777] - Eiichi Ogawa, Makoto Nakamuta, Toshimasa Koyanagi, Aritsune Ooho, Norihiro Furusyo, Eiji Kajiwara, Kazufumi Dohmen, Akira Kawano, Takeaki Satoh, Kazuhiro Takahashi, Koichi Azuma, Nobuyuki Yamashita, Naoki Yamashita, Rie Sugimoto, Hiromasa Amagase, Masami Kuniyoshi, Yasunori Ichiki, Chie Morita, Masaki Kato, Shinji Shimoda, Hideyuki Nomura, Jun Hayashi. Sequential HBV treatment with tenofovir alafenamide for patients with chronic hepatitis B: week 96 results from a real-world, multicenter cohort study.
Hepatology international.
2022 Apr; 16(2):282-293. doi:
10.1007/s12072-021-10295-3. [PMID: 35075593] - Joonho Jeong, Jung Woo Shin, Seok Won Jung, Eun Ji Park, Neung Hwa Park. Tenofovir alafenamide treatment may not worsen the lipid profile of chronic hepatitis B patients: A propensity score-matched analysis.
Clinical and molecular hepatology.
2022 04; 28(2):254-264. doi:
10.3350/cmh.2021.0314. [PMID: 34959261] - Derin Sevenler, Xin Niu, Sandy Dossantos, Mehmet Toner, Tim R Cressey, Rebecca D Sandlin, Paul K Drain. Point-of-care semi-quantitative test for adherence to tenofovir alafenamide or tenofovir disoproxil fumarate.
The Journal of antimicrobial chemotherapy.
2022 03; 77(4):996-999. doi:
10.1093/jac/dkab487. [PMID: 35038336] - Xiaoping Qian, Qi Chen, Yunhui Chen, Shiliang Ji, Ying Wang, Ye Sun, Huixin Qi, Kan Zhong, Jinfang Jiang, Xin Chen, Lifeng Huang, Yong Yang. A simple and fast LC-MS/MS method for the simultaneous determination of tenofovir alafenamide and tenofovir in human plasma.
Biomedical chromatography : BMC.
2022 Mar; 36(3):e5273. doi:
10.1002/bmc.5273. [PMID: 34725843] - Wenting Peng, Huimin Gu, Chuan Jiang, Jinqing Liu, Jian Zhang, Lei Fu. Comparison of tenofovir alafenamide and entecavir for hepatitis B virus-related acute-on-chronic liver failure.
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.
2022 Feb; 47(2):194-201. doi:
10.11817/j.issn.1672-7347.2022.210578. [PMID: 35545409] - A Geragotellis, S Patel, M Sonderup, N Wearne, Z Barday, L Sanglay, V Naicker, C W Spearman. Tenofovir alafenamide: An initial experience at Groote Schuur Hospital, Cape Town, South Africa.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
2022 Feb; 112(2):13505. doi:
NULL. [PMID: 35139993] - Yoshihito Uchida, Masamitsu Nakao, Shunsuke Yamada, Shohei Tsuji, Hayato Uemura, Jun-Ichi Kouyama, Kayoko Naiki, Kayoko Sugawara, Nobuaki Nakayama, Yukinori Imai, Tomoaki Tomiya, Satoshi Mochida. Superiority of tenofovir alafenamide fumarate over entecavir for serum HBsAg level reduction in patients with chronic HBV infection: A 144-week outcome study after switching of the nucleos(t)ide analog.
PloS one.
2022; 17(2):e0262764. doi:
10.1371/journal.pone.0262764. [PMID: 35180213] - Pimsiri Sripongpun, W Ray Kim, Ajitha Mannalithara, Allison Kwong, Tami Daugherty, Aparna Goel, Paul Y Kwo. Tenofovir Alafenamide Attenuates Effects of Diabetes and Body Mass on Serum Alanine Aminotransferase Activities in Patients With Chronic Hepatitis B.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
2022 01; 20(1):230-232. doi:
10.1016/j.cgh.2020.11.047. [PMID: 33285291] - Kazuharu Suzuki, Goki Suda, Yoshiya Yamamoto, Satoshi Abiko, Kenji Kinoshita, Shuichi Miyamoto, Ryo Sugiura, Megumi Kimura, Osamu Maehara, Ren Yamada, Takashi Kitagataya, Taku Shigesawa, Masatsugu Ohara, Naoki Kawagishi, Masato Nakai, Takuya Sho, Mitsuteru Natsuizaka, Kenichi Morikawa, Koji Ogawa, Naoya Sakamoto. Effect of switching from tenofovir disoproxil fumarate to tenofovir alafenamide on lipid profiles in patients with hepatitis B.
PloS one.
2022; 17(1):e0261760. doi:
10.1371/journal.pone.0261760. [PMID: 35051189] - Kensuke Abe, Taku Obara, Satomi Kamio, Asahi Kondo, Junji Imamura, Tatsuya Goto, Toshihiro Ito, Hiroshi Sato, Nobuyuki Takahashi. Renal function in Japanese HIV-1-positive patients who switch to tenofovir alafenamide fumarate after long-term tenofovir disoproxil fumarate: a single-center observational study.
AIDS research and therapy.
2021 12; 18(1):94. doi:
10.1186/s12981-021-00420-5. [PMID: 34876151] - Bo-Huang Liou, Chih-Ning Cheng, Ya-Ting Lin, Yu-Jou Lin, Yu-Chung Chuang, Kuan-Yin Lin, Wen-Chun Liu, Shu-Wen Lin, Ching-Hua Kuo, Hsin-Yun Sun, Chien-Ching Hung. Short-course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir/emtricitabine/tenofovir alafenamide.
Journal of the International AIDS Society.
2021 11; 24(11):e25844. doi:
10.1002/jia2.25844. [PMID: 34822220] - Laurence Brunet, Patrick Mallon, Jennifer S Fusco, Michael B Wohlfeiler, Girish Prajapati, Andrew Beyer, Gregory P Fusco. Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization.
Clinical drug investigation.
2021 Nov; 41(11):955-965. doi:
10.1007/s40261-021-01081-y. [PMID: 34546533] - Huan Xia, Xiao-Jie Huang, Yue Hu, Li-Ying Gao, Yue Wu, Hao Wu, Zhong-Fang Yan, Ping Ma. Switching from efavirenz to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide reduces central nervous system symptoms in people living with HIV.
Chinese medical journal.
2021 Oct; 134(23):2850-2856. doi:
10.1097/cm9.0000000000001824. [PMID: 34653085] - Arkaitz Imaz, Juan M Tiraboschi, Jordi Niubó, Javier Martinez-Picado, Mackenzie L Cottrell, Pere Domingo, Ivan Chivite, Eugenia Negredo, Amanda Schauer, Brian Van Horne, Sandra Morenilla, Víctor Urrea, Ana Silva-Klug, Sofía Scévola, Benito Garcia, Angela D M Kashuba, Daniel Podzamczer. Dynamics of the Decay of Human Immunodeficiency Virus (HIV) RNA and Distribution of Bictegravir in the Genital Tract and Rectum in Antiretroviral-naive Adults Living With HIV-1 Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (Spanish HIV/AIDS Research Network, PreEC/RIS 58).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
2021 10; 73(7):e1991-e1999. doi:
10.1093/cid/ciaa1416. [PMID: 32945851] - Baijun Li, Zhaozhe Liu, Xing Liu, Dongchun Liu, Mingyu Duan, Ye Gu, Qiong Liu, Qiang Ma, Yushi Wei, Yan Wang. Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load.
Hepatology international.
2021 Oct; 15(5):1103-1108. doi:
10.1007/s12072-021-10235-1. [PMID: 34312798] - Lucy Campbell, Birgit Barbini, Keith Burling, Ben Cromarty, Lisa Hamzah, Margaret Johnson, Rachael Jones, Amanda Samarawickrama, Deborah Williams, Alan Winston, Frank A Post. Safety of Tenofovir Alafenamide in People With HIV Who Experienced Proximal Renal Tubulopathy on Tenofovir Disoproxil Fumarate.
Journal of acquired immune deficiency syndromes (1999).
2021 10; 88(2):214-219. doi:
10.1097/qai.0000000000002747. [PMID: 34506361] - Pierre-Emmanuel Plum, Nathalie Maes, Anne-Sophie Sauvage, Frédéric Frippiat, Christelle Meuris, Françoise Uurlings, Marianne Lecomte, Philippe Léonard, Nicolas Paquot, Karine Fombellida, Dolores Vaira, Michel Moutschen, Gilles Darcis. Impact of switch from tenofovir disoproxil fumarate-based regimens to tenofovir alafenamide-based regimens on lipid profile, weight gain and cardiovascular risk score in people living with HIV.
BMC infectious diseases.
2021 Sep; 21(1):910. doi:
10.1186/s12879-021-06479-9. [PMID: 34488664] - Kelly A Johnson, Hideaki Okochi, David V Glidden, Monica Gandhi, Matthew Spinelli. Brief Report: No Difference in Urine Tenofovir Levels in Patients Living With HIV on Unboosted Versus Dose-Adjusted Boosted Tenofovir Alafenamide.
Journal of acquired immune deficiency syndromes (1999).
2021 09; 88(1):57-60. doi:
10.1097/qai.0000000000002727. [PMID: 33990489] - Thornthun Ueaphongsukkit, Sivaporn Gatechompol, Anchalee Avihingsanon, Jerasit Surintrspanont, Kroonpong Iampenkhae, Yingyos Avihingsanon, Suwasin Udomkarnjananun. Tenofovir alafenamide nephrotoxicity: a case report and literature review.
AIDS research and therapy.
2021 08; 18(1):53. doi:
10.1186/s12981-021-00380-w. [PMID: 34419091] - Lu Wang, Lina Wu, Xuejun Li, Ying Zhang, Jing Lai, Xiang Zhu, Chan Xie, Liang Peng. Tenofovir alafenamide fumarate therapy in subjects with positive HBV-DNA and normal levels of alanine transaminase: a study protocol for a randomised controlled trial.
BMJ open.
2021 08; 11(8):e048410. doi:
10.1136/bmjopen-2020-048410. [PMID: 34408049] - M Gutiérrez-Lorenzo, D Rubio-Calvo, J Urda-Romacho. [Effectiveness, safety, and economic impact of the bictegravir/emtricitabine/tenofovir alafenamide regimen in real clinical practice cohort of HIV-1 infected adult patients].
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.
2021 Aug; 34(4):315-319. doi:
10.37201/req/148.2020. [PMID: 34032111] - Mostafa Shokoohi, Meenakshi Gupta, Fred Crouzat, Graham Smith, Colin Kovacs, Jason Brunetta, Benny Chang, David Knox, Megan Acsai, Barry Merkley, Kevin Giolma, David Fletcher, Mona Loutfy. Changes in renal and metabolic indices after switching from tenofovir disoproxil fumarate- to tenofovir alafenamide-containing ART among individuals with HIV in Canada: A retrospective study.
International journal of STD & AIDS.
2021 08; 32(9):861-871. doi:
10.1177/0956462421999931. [PMID: 33890817] - Hidenori Toyoda, Jennifer Leong, Charles Landis, Masanori Atsukawa, Tsunamasa Watanabe, Daniel Q Huang, Joanne Liu, Sabrina Xin Zi Quek, Toru Ishikawa, Taeang Arai, Keisuke Yokohama, Makoto Chuma, Koichi Takaguchi, Haruki Uojima, Tomonori Senoo, Hansen Dang, Mayumi Maeda, Joseph Hoang, Richard H Le, Satoshi Yasuda, Khin N Thin, Sally Tran, Nicholas Chien, Linda Henry, Akira Asai, Shinya Fukunishi, Ramsey Cheung, Seng Gee Lim, Huy N Trinh, Mindie H Nguyen. Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine Practice.
Hepatology (Baltimore, Md.).
2021 08; 74(2):656-666. doi:
10.1002/hep.31793. [PMID: 33706421] - Paul E Sax, Jürgen K Rockstroh, Anne F Luetkemeyer, Yazdan Yazdanpanah, Douglas Ward, Benoit Trottier, Armin Rieger, Hui Liu, Rima Acosta, Sean E Collins, Diana M Brainard, Hal Martin. Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
2021 07; 73(2):e485-e493. doi:
10.1093/cid/ciaa988. [PMID: 32668455] - Thibault Mesplède. Evaluating the combination of emtricitabine/ tenofovir alafenamide fumarate to reduce the risk of sexually acquired HIV-1-infection in at-risk adults.
Expert opinion on pharmacotherapy.
2021 Jul; 22(10):1245-1251. doi:
10.1080/14656566.2021.1902504. [PMID: 33691554] - Naoki Kanda, Koh Okamoto, Hisatoshi Okumura, Makiko Mieno, Kentaro Sakashita, Teppei Sasahara, Shuji Hatakeyama. Outcomes associated with treatment change from tenofovir disoproxil fumarate to tenofovir alafenamide in HIV-1-infected patients: a real-world study in Japan.
HIV medicine.
2021 07; 22(6):457-466. doi:
10.1111/hiv.13061. [PMID: 33720508] - Juan Li, Chunhua Hu, Yi Chen, Rou Zhang, Shan Fu, Mimi Zhou, Zhijie Gao, Mengjun Fu, Taotao Yan, Yuan Yang, Jianzhou Li, Jinfeng Liu, Tianyan Chen, Yingren Zhao, Yingli He. Short-term and long-term safety and efficacy of tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir treatment of acute-on-chronic liver failure associated with hepatitis B.
BMC infectious diseases.
2021 Jun; 21(1):567. doi:
10.1186/s12879-021-06237-x. [PMID: 34126939] - Oliver Ackaert, David McDougall, Carlos Pérez-Ruixo, Juan Jose Pérez-Ruixo, John Jezorwski, Herta M Crauwels. Population Pharmacokinetic Analysis of Darunavir and Tenofovir Alafenamide in HIV-1-Infected Patients on the Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen (AMBER and EMERALD Studies).
The AAPS journal.
2021 06; 23(4):82. doi:
10.1208/s12248-021-00607-8. [PMID: 34100149] - Mina S Farag, Scott Fung, Edward Tam, Karen Doucette, Alexander Wong, Alnoor Ramji, Brian Conway, Curtis Cooper, Keith Tsoi, Philip Wong, Giada Sebastiani, Mayur Brahmania, Sarah Haylock-Jacobs, Carla S Coffin, Bettina E Hansen, Harry L A Janssen. Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real-World Study.
Journal of viral hepatitis.
2021 06; 28(6):942-950. doi:
10.1111/jvh.13500. [PMID: 33749086] - Maria Buti, Cristina Marcos-Fosch, Rafael Esteban. Nucleos(t)ide analogue therapy: The role of tenofovir alafenamide.
Liver international : official journal of the International Association for the Study of the Liver.
2021 06; 41 Suppl 1(?):9-14. doi:
10.1111/liv.14848. [PMID: 34155802] - Bernard Surial, Catrina Mugglin, Alexandra Calmy, Matthias Cavassini, Huldrych F Günthard, Marcel Stöckle, Enos Bernasconi, Patrick Schmid, Philip E Tarr, Hansjakob Furrer, Bruno Ledergerber, Gilles Wandeler, Andri Rauch. Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV : A Cohort Study.
Annals of internal medicine.
2021 06; 174(6):758-767. doi:
10.7326/m20-4853. [PMID: 33721521] - Emma Touizer, Aljawharah Alrubayyi, Chloe Rees-Spear, Natasha Fisher-Pearson, Sarah A Griffith, Luke Muir, Pierre Pellegrino, Laura Waters, Fiona Burns, Sabine Kinloch, Sarah Rowland-Jones, Ravindra K Gupta, Richard Gilson, Dimitra Peppa, Laura E McCoy. Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV.
The lancet. HIV.
2021 06; 8(6):e317-e318. doi:
10.1016/s2352-3018(21)00099-0. [PMID: 34087093] - Gianmaria Baldin, Arturo Ciccullo, Francesca Lombardi, Anna D'Angelillo, Alex Dusina, Arianna Emiliozzi, Damiano Farinacci, Davide Moschese, Chiara Picarelli, Alberto Borghetti, Simona Di Giambenedetto. Short Communication: Comparing Lamivudine+Dolutegravir and Bictegravir/Emtricitabine/Tenofovir Alafenamide as Switch Strategies: Preliminary Results from Clinical Practice.
AIDS research and human retroviruses.
2021 06; 37(6):429-432. doi:
10.1089/aid.2020.0219. [PMID: 33280486] - Mahoko Ikeda, Yoshitaka Wakabayashi, Koh Okamoto, Shintaro Yanagimoto, Shu Okugawa, Kyoji Moriya. Changing trends in lipid profile and biomarkers of renal function and bone metabolism before and after switching from tenofovir disoproxil fumarate to tenofovir alafenamide: a prospective observational study.
AIDS research and therapy.
2021 05; 18(1):30. doi:
10.1186/s12981-021-00354-y. [PMID: 34044856] - Teodora Pene Dumitrescu, Samit R Joshi, Jianfeng Xu, Joyce Zhan, Mark Johnson, Laurie Butcher, Eric Zimmerman, Lindsey Webster, Antonia M Davidson, Max Lataillade, Sherene Min. A Phase I Evaluation of the Pharmacokinetics and Tolerability of the HIV-1 Maturation Inhibitor GSK3640254 and Tenofovir Alafenamide/Emtricitabine in Healthy Participants.
Antimicrobial agents and chemotherapy.
2021 05; 65(6):. doi:
10.1128/aac.02173-20. [PMID: 33753329] - Fehmi Tabak, Esra Zerdali, Ozlem Altuntaş, Alper Gunduz, Sibel Bolukcu, Bilgul Mete, Inci Y Nakir, Hayat Kumbasar Karaosmanoglu, Dilek S Yildiz, Meliha Meric Koc, İlyas Dokmetas. Efficacy and safety of co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in HIV-positive patients: real-world data.
International journal of STD & AIDS.
2021 05; 32(6):562-569. doi:
10.1177/0956462420983692. [PMID: 33599173] - Yu-Shan Huang, Chien-Yu Cheng, Bo-Huang Liou, Po-Liang Lu, Shu-Hsing Cheng, Yuan-Ti Lee, Chun-Eng Liu, Hsin-Yun Sun, Chia-Jui Yang, Hung-Jen Tang, Shih-Ping Lin, Mao-Wang Ho, Sung-Hsi Huang, Hung-Chin Tsai, Chen-Hsiang Lee, Chien-Ching Hung. Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients.
Journal of acquired immune deficiency syndromes (1999).
2021 04; 86(4):473-481. doi:
10.1097/qai.0000000000002589. [PMID: 33273214] - Yeqiong Zhang, Wenxiong Xu, Xiang Zhu, Xuejun Li, Jianguo Li, Xin Shu, Jing Lai, Junqiang Xie, Chan Xie, Liang Peng. The 48-week safety and therapeutic effects of tenofovir alafenamide in hbv-related acute-on-chronic liver failure: A prospective cohort study.
Journal of viral hepatitis.
2021 04; 28(4):592-600. doi:
10.1111/jvh.13468. [PMID: 33423348] - Subhra Mandal, Pavan Kumar Prathipati, Shawnalyn W Sunagawa, Christopher J Destache. A Concept Evaluation Study of a New Combination Bictegravir plus Tenofovir Alafenamide Nanoformulation with Prolonged Sustained-Drug-Release Potency for HIV-1 Preexposure Prophylaxis.
Antimicrobial agents and chemotherapy.
2021 03; 65(4):. doi:
10.1128/aac.02320-20. [PMID: 33526487] - A Deiva, V Jayaprakash, Nisha Jose, K N Chandan Kumar, M Jayakumar. Acute kidney injury in a patient treated with tenofovir alafenamide fumarate for Hepatitis B virus infection.
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.
2021 Mar; 32(2):592-594. doi:
10.4103/1319-2442.335480. [PMID: 35017362] - Elena Bekerman, Stephanie Cox, Darius Babusis, Federico Campigotto, Moupali Das, Dan H Barouch, Tomas Cihlar, Christian Callebaut. Two-dose emtricitabine/tenofovir alafenamide plus bictegravir prophylaxis protects macaques against SHIV infection.
The Journal of antimicrobial chemotherapy.
2021 02; 76(3):692-698. doi:
10.1093/jac/dkaa476. [PMID: 33202006] - L Gazzola, G Tagliaferri, A De Bona, D Mondatore, C Borsino, T Bini, G Marchetti, A d'Arminio Monforte. Dyslipidaemia after switch to tenofovir alafenamide (TAF)-based cART regimens in a cohort of HIV-positive patients: what clinical relevance?.
HIV medicine.
2021 02; 22(2):140-145. doi:
10.1111/hiv.12984. [PMID: 33084173] - Qiuying Li, Lihui Jia, Wenli Hu, Shu Dong, Chaohong Cai. Bioequivalence Evaluation of Two Formulations of Tenofovir Alafenamide Tablets in Healthy Subjects Under Fasting and Fed Conditions.
Drug design, development and therapy.
2021; 15(?):2551-2562. doi:
10.2147/dddt.s304108. [PMID: 34163141] - Victoria Pilkington, Sophie L Hughes, Toby Pepperrell, Kaitlyn McCann, Dzintars Gotham, Anton L Pozniak, Andrew Hill. Tenofovir alafenamide vs. tenofovir disoproxil fumarate: an updated meta-analysis of 14 894 patients across 14 trials.
AIDS (London, England).
2020 12; 34(15):2259-2268. doi:
10.1097/qad.0000000000002699. [PMID: 33048869] - Anna Hung, Matthew Sinclair, Marion Hemmersbach-Miller, Daniel Edmonston, Christina Wyatt. Prescribing rates and characteristics of recipients of tenofovir-containing regimens before and after market entry of tenofovir alafenamide.
Journal of managed care & specialty pharmacy.
2020 Dec; 26(12):1582-1588. doi:
10.18553/jmcp.2020.26.12.1582. [PMID: 33251997] - Giovanni Di Perri. Tenofovir alafenamide revisited.
Le infezioni in medicina.
2020 Dec; 28(4):525-533. doi:
". [PMID: 33257626] - Kristina M Brooks, Jose R Castillo-Mancilla, Mary Morrow, Samantha MaWhinney, Joshua Blum, David L Wyles, Sarah E Rowan, Mustafa E Ibrahim, Jia-Hua Zheng, Bethany Johnson, Joe Gomez, Ye Ji Choi, Francesca Cendali, Hannah Haas, Laura Roon, Lane R Bushman, Peter L Anderson, Jennifer J Kiser. Pharmacokinetics and renal safety of tenofovir alafenamide with boosted protease inhibitors and ledipasvir/sofosbuvir.
The Journal of antimicrobial chemotherapy.
2020 11; 75(11):3303-3310. doi:
10.1093/jac/dkaa299. [PMID: 32766700] - Courtney V Fletcher, Anthony T Podany, Ann Thorkelson, Lee C Winchester, Timothy Mykris, Jodi Anderson, Siri Jorstad, Jason V Baker, Timothy W Schacker. The Lymphoid Tissue Pharmacokinetics of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide in HIV-Infected Persons.
Clinical pharmacology and therapeutics.
2020 11; 108(5):971-975. doi:
10.1002/cpt.1883. [PMID: 32385902] - Alexander Morales, John Danziger. Management Consideration in Drug-Induced Lactic Acidosis.
Clinical journal of the American Society of Nephrology : CJASN.
2020 10; 15(10):1511-1512. doi:
10.2215/cjn.14781219. [PMID: 32444396] - Willem D F Venter, Simiso Sokhela, Bryony Simmons, Michelle Moorhouse, Lee Fairlie, Nkuli Mashabane, Celicia Serenata, Godspower Akpomiemie, Masebole Masenya, Ambar Qavi, Nomathemba Chandiwana, Kaitlyn McCann, Shane Norris, Matthew Chersich, Gary Maartens, Samanta Lalla-Edward, Alinda Vos, Polly Clayden, Elaine Abrams, Natasha Arulappan, Andrew Hill. Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial.
The lancet. HIV.
2020 10; 7(10):e666-e676. doi:
10.1016/s2352-3018(20)30241-1. [PMID: 33010240] - Guan-Jhou Chen, Yu-Lin Lee, Chen-Hsiang Lee, Hsin-Yun Sun, Chien-Yu Cheng, Hung-Chin Tsai, Sung-Hsi Huang, Yi-Chieh Lee, Min-Han Hsieh, Sui-Yuan Chang, Yu-Chung Chuang, Li-Shin Su, Sui-Fang Chang, Hung-Jen Tang, Chien-Ching Hung. Impact of archived M184V/I mutation on the effectiveness of switch to co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide among virally suppressed people living with HIV.
The Journal of antimicrobial chemotherapy.
2020 10; 75(10):2986-2993. doi:
10.1093/jac/dkaa287. [PMID: 32737511] - Bernard Surial, Charles Béguelin, Jean-Philippe Chave, Marcel Stöckle, Noémie Boillat-Blanco, Thanh Doco-Lecompte, Enos Bernasconi, Jan Fehr, Huldrych F Günthard, Patrick Schmid, Laura N Walti, Hansjakob Furrer, Andri Rauch, Gilles Wandeler. Brief Report: Switching From TDF to TAF in HIV/HBV-Coinfected Individuals With Renal Dysfunction-A Prospective Cohort Study.
Journal of acquired immune deficiency syndromes (1999).
2020 10; 85(2):227-232. doi:
10.1097/qai.0000000000002429. [PMID: 32925387] - F Ibrahim, L Campbell, A C Bailey, S Stockwell, L Waters, C Orkin, M Johnson, M Gompels, A De Burgh-Thomas, R Jones, G Schembri, P W Mallon, F A Post. Estimated glomerular filtration rate slopes on tenofovir alafenamide.
HIV medicine.
2020 10; 21(9):607-612. doi:
10.1111/hiv.12899. [PMID: 33021067] - Vasilis Petrakis, Periklis Panagopoulos, Stella Papachristou, Nikolaos Papanas, Irene Terzi, Grigorios Trypsianis, Dimitrios Papazoglou. Tenofovir Alafenamide Fumarate Therapy for HIV Treatment: Cardiometabolic and Renal Safety.
AIDS research and human retroviruses.
2020 09; 36(9):697-702. doi:
10.1089/aid.2019.0280. [PMID: 32527142] - Teresa L Parsons, Kevin N Gwenden, Mark A Marzinke. Interspecies Differences in Tenofovir Alafenamide Fumarate Stability in Plasma.
Antimicrobial agents and chemotherapy.
2020 08; 64(9):. doi:
10.1128/aac.00930-20. [PMID: 32540983] - Qing Ma, Andrew J Ocque, Gene D Morse, Chelsea Sanders, Alina Burgi, Susan J Little, Scott L Letendre. Switching to Tenofovir Alafenamide in Elvitegravir-Based Regimens: Pharmacokinetics and Antiviral Activity in Cerebrospinal Fluid.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
2020 08; 71(4):982-988. doi:
10.1093/cid/ciz926. [PMID: 31560741] - Jack E Heron, Mark Bloch, Vinay Vanguru, John Saunders, David M Gracey. Renal proximal tubulopathy in an HIV-infected patient treated with tenofovir alafenamide and gentamicin: a case report.
BMC nephrology.
2020 08; 21(1):339. doi:
10.1186/s12882-020-01981-9. [PMID: 32787843] - Bernard Surial, Bruno Ledergerber, Alexandra Calmy, Matthias Cavassini, Huldrych F Günthard, Helen Kovari, Marcel Stöckle, Enos Bernasconi, Patrick Schmid, Christoph A Fux, Hansjakob Furrer, Andri Rauch, Gilles Wandeler. Changes in Renal Function After Switching From TDF to TAF in HIV-Infected Individuals: A Prospective Cohort Study.
The Journal of infectious diseases.
2020 07; 222(4):637-645. doi:
10.1093/infdis/jiaa125. [PMID: 32189003] - Rajith K R Rajoli, Zach R Demkovich, Charles Flexner, Andrew Owen, Marco Siccardi. Predicting Pharmacokinetics of a Tenofovir Alafenamide Subcutaneous Implant Using Physiologically Based Pharmacokinetic Modelling.
Antimicrobial agents and chemotherapy.
2020 07; 64(8):. doi:
10.1128/aac.00155-20. [PMID: 32423957] - Collins C Iwuji, Duncan Churchill, Stephen Bremner, Nicky Perry, Ye To, Debbie Lambert, Chloe Bruce, Laura Waters, Chloe Orkin, Anna Maria Geretti. A phase IV randomised, open-label pilot study to evaluate switching from protease-inhibitor based regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide single tablet regimen in Integrase inhibitor-naïve, virologically suppressed HIV-1 infected adults harbouring drug resistance mutations (PIBIK study): study protocol for a randomised trial.
BMC infectious diseases.
2020 Jul; 20(1):524. doi:
10.1186/s12879-020-05240-y. [PMID: 32689975] - Eiichi Ogawa, Hideyuki Nomura, Makoto Nakamuta, Norihiro Furusyo, Toshimasa Koyanagi, Kazufumi Dohmen, Aritsune Ooho, Takeaki Satoh, Akira Kawano, Eiji Kajiwara, Kazuhiro Takahashi, Koichi Azuma, Masaki Kato, Shinji Shimoda, Jun Hayashi. Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B.
Liver international : official journal of the International Association for the Study of the Liver.
2020 07; 40(7):1578-1589. doi:
10.1111/liv.14482. [PMID: 32304611] - C Schwarze-Zander, H Piduhn, C Boesecke, S Schlabe, B Stoffel-Wagner, J C Wasmuth, C P Strassburg, J K Rockstroh. Switching tenofovir disoproxil fumarate to tenofovir alafenamide in a real life setting: what are the implications?.
HIV medicine.
2020 07; 21(6):378-385. doi:
10.1111/hiv.12840. [PMID: 32065713] - Aoife Lacey, Stefano Savinelli, Elena Alvarez Barco, Alan Macken, Aoife G Cotter, Gerard Sheehan, John S Lambert, Eavan Muldoon, Eoin Feeney, Patrick W Mallon, Willard Tinago. Investigating the effect of antiretroviral switch to tenofovir alafenamide on lipid profiles in people living with HIV.
AIDS (London, England).
2020 07; 34(8):1161-1170. doi:
10.1097/qad.0000000000002541. [PMID: 32310899] - Ying Jiang, Xinyi Gao, Onkar N Singh, Wei Zhang, Vivek Agrahari, M Melissa Peet, Meredith R Clark, Gustavo F Doncel, Ajay K Banga. Pharmacokinetics of a weekly transdermal delivery system of tenofovir alafenamide in hairless rats.
International journal of pharmaceutics.
2020 May; 582(?):119342. doi:
10.1016/j.ijpharm.2020.119342. [PMID: 32315746] - Manuel Vélez-Díaz-Pallarés, Teresa Gramage-Caro, Miguel Ángel Rodríguez-Sagrado, Beatriz Montero-Llorente, Teresa Bermejo-Vicedo. Satisfaction and knowledge among patients with HIV after switching from tenofovir to tenofovir alafenamide in regimens containing emtricitabine and rilpivirine.
Biomedica : revista del Instituto Nacional de Salud.
2020 05; 40(Supl. 1):132-138. doi:
10.7705/biomedica.4989. [PMID: 32463615] - Lung-Yi Mak. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide: perhaps not as simple as we thought.
The lancet. Gastroenterology & hepatology.
2020 05; 5(5):420-421. doi:
10.1016/s2468-1253(19)30450-9. [PMID: 32087794] - Chloe Orkin, Joseph J Eron, Jürgen Rockstroh, Daniel Podzamczer, Stefan Esser, Linos Vandekerckhove, Erika Van Landuyt, Erkki Lathouwers, Veerle Hufkens, John Jezorwski, Magda Opsomer. Week 96 results of a phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients.
AIDS (London, England).
2020 04; 34(5):707-718. doi:
10.1097/qad.0000000000002463. [PMID: 31833849] - Xingbao Tao, Yanqiu Lu, Yihong Zhou, Lvlang Zhang, Yaokai Chen. Efficacy and safety of the regimens containing tenofovir alafenamide versus tenofovir disoproxil fumarate in fixed-dose single-tablet regimens for initial treatment of HIV-1 infection: A meta-analysis of randomized controlled trials.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
2020 Apr; 93(?):108-117. doi:
10.1016/j.ijid.2020.01.035. [PMID: 31988012] - Cheng-Chun Tai, Ruey-Yi Chou, Jiun-Yu Guo, Hsin-Pai Chen. Severe acute hypokalaemia associated with piperacillin/tazobactam in an HIV-infected patient under antiretroviral therapy with tenofovir alafenamide: case report and literature review.
Sexual health.
2020 Apr; 17(2):194-197. doi:
10.1071/sh19069. [PMID: 32119813] - Deqing Xiao, Kah Hiing John Ling, Thomas Tarnowski, Sophia R Majeed, Polina German, Brian P Kearney, Yuwen Zhao, Yuan-Shek Chen, Lili Ma, Tianyi Zhang. An LC-MS/MS method for determination of tenofovir (TFV) in human plasma following tenofovir alafenamide (TAF) administration: Development, validation, cross-validation, and use of formic acid as plasma TFV stabilizer.
Analytical biochemistry.
2020 03; 593(?):113611. doi:
10.1016/j.ab.2020.113611. [PMID: 32035040] - L Hamzah, D Williams, A C Bailey, R Jones, F Ibrahim, C G Musso, K Burling, B Barbini, L Campbell, F A Post. Early safety of tenofovir alafenamide in patients with a history of tubulopathy on tenofovir disoproxil fumarate: a randomized controlled clinical trial.
HIV medicine.
2020 03; 21(3):198-203. doi:
10.1111/hiv.12819. [PMID: 31679186] - Yoshihito Uchida, Masamitsu Nakao, Shohei Tsuji, Hayato Uemura, Jun-Ichi Kouyama, Kayoko Naiki, Daisuke Motoya, Kayoko Sugawara, Nobuaki Nakayama, Yukinori Imai, Tomoaki Tomiya, Satoshi Mochida. Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate.
Journal of medical virology.
2020 03; 92(3):329-338. doi:
10.1002/jmv.25644. [PMID: 31777965] - Po-Hsien Kuo, Hsin-Yun Sun, Yu-Chung Chuang, Pei-Ying Wu, Wen-Chun Liu, Chien-Ching Hung. Weight gain and dyslipidemia among virally suppressed HIV-positive patients switching to co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
2020 Mar; 92(?):71-77. doi:
10.1016/j.ijid.2019.12.029. [PMID: 31884172] - Jonathan T Su, Solange M Simpson, Samuel Sung, Ewa Bryndza Tfaily, Ronald Veazey, Mark Marzinke, Jiang Qiu, David Watrous, Lakmini Widanapathirana, Elizabeth Pearson, M Melissa Peet, Dipu Karunakaran, Brooke Grasperge, Georgina Dobek, Charlette M Cain, Thomas Hope, Patrick F Kiser. A Subcutaneous Implant of Tenofovir Alafenamide Fumarate Causes Local Inflammation and Tissue Necrosis in Rabbits and Macaques.
Antimicrobial agents and chemotherapy.
2020 02; 64(3):. doi:
10.1128/aac.01893-19. [PMID: 31871073] - Ganesh S Moorthy, Linden Lalley-Chareczko, Helen C Koenig, Athena F Zuppa. Tenofovir Urine Assay to Monitor Adherence to HIV Pre-exposure Prophylaxis.
Current clinical pharmacology.
2020; 15(2):102-104. doi:
10.2174/1574884714666191111125348. [PMID: 31713497] - Nicola Squillace, Elena Ricci, Barbara Menzaghi, Giuseppe Vittorio De Socio, Simone Passerini, Canio Martinelli, Maria Sabrina Mameli, Paolo Maggi, Katia Falasca, Laura Cordier, Benedetto Maurizio Celesia, Elena Salomoni, Antonio Di Biagio, Giovanni Francesco Pellicanò, Paolo Bonfanti. The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile.
Drug design, development and therapy.
2020; 14(?):5515-5520. doi:
10.2147/dddt.s274307. [PMID: 33364747] - Dane Turner, Douglas Drak, Catherine C O'Connor, David J Templeton, David M Gracey. Renal function change after switching tenofovir disoproxil fumarate for tenofovir alafenamide in the HIV-positive patients of a metropolitan sexual health service.
AIDS research and therapy.
2019 12; 16(1):40. doi:
10.1186/s12981-019-0256-9. [PMID: 31810490]